Curated News
By: NewsRamp Editorial Staff
May 12, 2026
Older Americans Turn to Cannabis as Alternative to Pharmaceuticals
TLDR
- TerrAscend Corp. could gain market share as older adults increasingly choose cannabis over pharmaceuticals.
- A federally funded AMA study shows older adults turning to cannabis as an alternative to traditional medical treatments.
- Older adults find relief in cannabis after struggling with pharmaceuticals, improving their quality of life.
- Many older Americans are using marijuana for medical relief, not recreation, according to a new AMA study.
Impact - Why it Matters
This matters because it signals a major shift in how seniors manage health conditions, moving away from traditional pharmaceuticals toward cannabis. For readers, this could mean more accessible and potentially safer options for pain relief and other ailments. It also opens investment opportunities in cannabis companies like TerrAscend that cater to this demographic, and may drive policy changes as demand grows.
Summary
A newly released federally backed study suggests that many older Americans are turning to cannabis not for recreation, but in search of relief after struggling with traditional medical treatments. The research, published by the American Medical Association, indicates a growing trend among seniors using marijuana as an alternative to pharmaceuticals, often for chronic pain, sleep issues, and anxiety. This shift could have significant implications for the healthcare industry and pharmaceutical companies, as more patients seek natural remedies.
Marijuana firms like TerrAscend Corp. (TSX: TSND) (OTCQX: TSNDF) could weigh the opportunity of coming up with products tailored to this demographic. TerrAscend, a leading cannabis operator in North America, is well-positioned to capitalize on the increasing demand from older adults for medical marijuana. The company offers a range of cannabis products, including flower, oils, and edibles, which may appeal to seniors seeking discreet and easy-to-dose options. As regulatory landscapes evolve, companies like TerrAscend are expanding their footprint to meet the needs of this growing consumer base.
The study's findings underscore a broader societal shift toward accepting cannabis as a legitimate medical treatment. With more older adults choosing cannabis over conventional pharmaceuticals, this could lead to reduced reliance on opioids and other prescription drugs, potentially lowering healthcare costs. For investors, this trend highlights opportunities in the cannabis sector, particularly for companies focusing on medical applications. To read the full story, click Read More>>.
Source Statement
This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, Older Americans Turn to Cannabis as Alternative to Pharmaceuticals
